Glycoprotein V : the unsolved GPV puzzle

References

• Phillips DR, Agin PP. Platelet plasma membrane glycoproteins Identification of a proteolytic substrate for thrombin. Biochem Biophys Res Commun 1977 Apr 25;75(4):940–947. doi:10.1016/0006-291X(77)91473-5.
   PubMed Web of Science ®Google Scholar
• Mosher D, Vaheri A, Choate J, Gahmberg C. Action of thrombin on surface glycoproteins of human platelets. Blood 1979 Mar;53(3):437–445. doi:10.1182/blood.V53.3.437.437.
   PubMed Web of Science ®Google Scholar
• Berndt MC, Phillips DR. Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. J Biol Chem 1981 Jan 10;256(1):59–65. doi:10.1016/S0021-9258(19)70097-0.
   PubMed Web of Science ®Google Scholar
• Wicki AN, Clemetson KJ. Structure and function of platelet membrane glycoproteins Ib and V: effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Eur J Biochem 1985 Nov 15;153(1):1–11. doi:10.1111/j.1432-1033.1985.tb09259.x.
   PubMedGoogle Scholar
• Clemetson KJ, McGregor JL, James E, Dechavanne M, Lüscher EF. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982 Aug;70(2):304–311. doi:10.1172/JCI110618.
   PubMed Web of Science ®Google Scholar
• Modderman PW, Admiraal LG, Sonnenberg A, Von Dem Borne AEGK. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992 Jan 5;267(1):364–369. doi:10.1016/S0021-9258(18)48503-1.
   PubMed Web of Science ®Google Scholar
• Lanza F, Morales M, de La Salle C, Cazenave JP, Clemetson KJ, Shimomura T, Phillips DR. Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. J Biol Chem 1993;268(28):20801–20807. doi:10.1016/S0021-9258(19)36855-3.
   PubMed Web of Science ®Google Scholar
• Hickey MJ, Hagen FS, Yagi M, Roth GJ. Human platelet glycoprotein V: characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins. Proc Natl Acad Sci U S A 1993 Sep 15;90(18):8327–8331. doi:10.1073/pnas.90.18.8327.
   PubMed Web of Science ®Google Scholar
• Azorsa DO, Moog S, Ravanat C, Schuhler S, Folléa G, Cazenave JP, Lanza F. Measurement of GPV released by activated platelets using a sensitive immunocapture ELISA - Its use to follow platelet storage in transfusion. Thromb Haemost 1999 Jan;81(1):131–138. doi:10.1055/s-0037-1614430.
   PubMed Web of Science ®Google Scholar
• Li CQ, Dong JF, Lanza F, Sanan DA, Sae-Tung G, Lopez JA. Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GP Ibα in forming a GP Ib-IX-V complex on the cell surface. J Biol Chem 1995 Jul 7;270(27):16302–16307. doi:10.1074/jbc.270.27.16302.
   PubMed Web of Science ®Google Scholar
• Strassel C, Moog S, Baas MJ, Cazenave JP, Lanza F. Biosynthesis of platelet glycoprotein V expressed as a single subunit or in association with GPIb-IX. Eur J Biochem 2004 Sep;271(18):3671–3677. doi:10.1111/j.1432-1033.2004.04304.x.
   PubMedGoogle Scholar
• Li R, Emsley J. The organizing principle of the platelet glycoprotein Ib-IX-V complex. J Thromb Haemost 2013 Apr;11(4):605–614. doi:10.1111/jth.12144.
   PubMed Web of Science ®Google Scholar
• Mo X, Liu L, López JA, Li R. Transmembrane domains are critical to the interaction between platelet glycoprotein V and glycoprotein Ib-IX complex. J Thromb Haemost 2012 Sep;10(9):1875–1886. doi:10.1111/j.1538-7836.2012.04841.x.
   PubMed Web of Science ®Google Scholar
• Hourdille P, Heilmann E, Combrie R, Winckler J, Clemetson K, Nurden A. Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the membrane systems of activated human platelets. Blood 1990;76(8):1503–1513. doi:10.1182/blood.V76.8.1503.1503.
   PubMed Web of Science ®Google Scholar
• Kovacsovics T, Hartwig J. Thrombin-induced GPIb-IX centralization on the platelet surface requires actin assembly and myosin II activation. Blood 1996;87(2):618–629. doi:10.1182/blood.V87.2.618.bloodjournal872618.
   PubMed Web of Science ®Google Scholar
• Michelson A, Benoit S, Furman M, Barnard M, Nurden P, Nurden A. The platelet surface expression of glycoprotein V is regulated by two independent mechanisms: proteolysis and a reversible cytoskeletal- mediated redistribution to the surface-connected canalicular system. Blood 1996;87(4):1396–1408. doi:10.1182/blood.V87.4.1396.bloodjournal8741396.
   PubMed Web of Science ®Google Scholar
• Ravanat C, Morales M, Azorsa DO, Moog S, Schuhler S, Grunert P, Loew D, Van Dorsselaer A, Cazenave JP, Lanza F. Gene cloning of rat and mouse platelet glycoprotein V: identification of megakaryocyte-specific promoters and demonstration of functional thrombin cleavage. Blood 1997 May 1;89(9):3253–3262. doi:10.1182/blood.V89.9.3253.
   PubMed Web of Science ®Google Scholar
• Li R. The glycoprotein Ib-IX-V complex. In: Michelson AD, Cattaneo M, Frelinger L, Newman PJ, editors. Platelets. 4th ed. London, San Diego, Cambridge and Kidlington: Elsevier/Academic Press; 2019. p. 193–211. ISBN: 9780128134566. doi:10.1016/B978-0-12-813456-6.00010-2.
   Google Scholar
• Shimomura T, Fujimura K, Maehama S, Takemoto M, Oda K, Fujimoto T, Oyama R, Suzuki M, Ichihara-Tanaka K, Titani K, et al. Rapid purification and characterization of human platelet glycoprotein V: the amino acid sequence contains leucine-rich repetitive modules as in glycoprotein Ib. Blood 1990 Jun 15;75(12):2349–2356. doi:10.1182/blood.V75.12.2349.2349.
   PubMed Web of Science ®Google Scholar
• Potts KS, Sargeant TJ, Dawson CA, Josefsson EC, Hilton DJ, Alexander WS, Taoudi S. Mouse prenatal platelet-forming lineages share a core transcriptional program but divergent dependence on MPL. Blood 2015 Aug 6;126(6):807–816. doi:10.1182/blood-2014-12-616607.
   PubMed Web of Science ®Google Scholar
• Poujol C, Ramakrishnan V, DeGuzman F, Nurden A, Phillips D, Nurden P. Ultrastructural analysis of megakaryocytes in GPV knockout mice. Thromb Haemost 2000;84(8):312–318. doi:10.1055/s-0037-1614013.
   PubMedGoogle Scholar
• Lepage A, Leboeuf M, Cazenave JP, De La Salle C, Lanza F, Uzan G. The αIIbß3 integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34+ cord blood cells to megakaryocytes. Blood 2000 Dec 15;96(13):4169–4177. doi:10.1182/blood.V96.13.4169.
   PubMed Web of Science ®Google Scholar
• Lepage A, Uzan G, Touche N, Morales M, Cazenave JP, Lanza F, De La Salle C. Functional characterization of the human platelet glycoprotein V gene promoter: a specific marker of late megakaryocytic differentiation. Blood 1999 Nov 15;94(10):3366–3380. doi:10.1182/blood.V94.10.3366.422k35_3366_3380.
   PubMed Web of Science ®Google Scholar
• Koskela S, Kekomäki R, Partanen J. Genetic polymorphism in human platelet glycoprotein GP Ib/IX/V complex is enriched in GP V (CD42d). Tissue Antigens 1998 Sep;52(3):236–241. doi:10.1111/j.1399-0039.1998.tb03038.x.
   PubMedGoogle Scholar
• Meenaghan M, Judson PA, Yousaf K, Lewis L, Pamphilon DH. Antibodies to platelet glycoprotein V in polytransfused patients with haematological disease. Vox Sang 1993;64(3):167–170. doi:10.1111/j.1423-0410.1993.tb05156.x.
   PubMed Web of Science ®Google Scholar
• Mayer JLR, Beardsley DS. Varicella-associated thrombocytopenia: autoantibodies against platelet surface glycoprotein V. Pediatr Res 1996 Oct;40(4):615–619. doi:10.1203/00006450-199610000-00017.
   PubMed Web of Science ®Google Scholar
• Stricker RB, Shuman MA. Quinidine purpura: evidence that glycoprotein V is a target platelet antigen. Blood 1986 May;67(5):1377–1381. doi:10.1182/blood.V67.5.1377.1377.
   PubMed Web of Science ®Google Scholar
• Garner SF, Campbell K, Metcalfe P, Keidan J, Huiskes E, Dong JF, López JA, Ouwehand WH, Glycoprotein V. The predominant target antigen in gold-induced autoimmune thrombocytopenia. Blood 2002 Jul 1;100(1):344–346. doi:10.1182/blood.V100.1.344.
   PubMed Web of Science ®Google Scholar
• Joutsi-Korhonen L, Javela K, Hormila P, Kekomäki R. Glycoprotein V-specific platelet-associated antibodies in thrombocytopenic patients. Clin Lab Haematol Suppl 2001 Oct;23(5):307–312. doi:10.1046/j.1365-2257.2001.00405.x.
   PubMedGoogle Scholar
• Vollenberg R, Jouni R, Norris PAA, Burg-Roderfeld M, Cooper N, Rummel MJ, Bein G, Marini I, Bayat B, Burack R, et al. Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia. Haematologica 2019 Jun;104(6):1237–1243. doi:10.3324/haematol.2018.211086.
   PubMed Web of Science ®Google Scholar
• Li R, Hoffmeister KM, Falet H. Glycans and the platelet life cycle. Platelets 2016 Sep;27(6):505–511. doi:10.3109/09537104.2016.1171304.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007 Jul;5(7):1530–1537. doi:10.1111/j.1538-7836.2007.02590.x.
   PubMed Web of Science ®Google Scholar
• Mcgowan EB, Yeo KT, Detwiler TC. The action of calcium-dependent protease on platelet surface glycoproteins. Arch Biochem Biophys 1983 Nov;227(1):287–301. doi:10.1016/0003-9861(83)90373-9.
   PubMed Web of Science ®Google Scholar
• Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005 Apr 15;280(15):14462–14468. doi:10.1074/jbc.M500041200.
   PubMed Web of Science ®Google Scholar
• Ravanat C, Freund M, Mangin P, Azorsa DO, Schwartz C, Moog S, Schuhler S, Dambach J, Cazenave JP, Lanza F. GPV is a marker of in vivo platelet activation - Study in a rat thrombosis model. Thromb Haemost 2000 Feb;83(2):327–333. doi:10.1055/s-0037-1613807.
   PubMed Web of Science ®Google Scholar
• Blann AD, Lanza F, Galajda P, Gurney D, Moog S, Cazenave JP, Lip GYH. Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis: the influence of aspirin and cigarette smoking. Thromb Haemost 2001 Sep;86(3):777–783. doi:10.1055/s-0037-1616131.
   PubMed Web of Science ®Google Scholar
• Aleil B, Mossard JM, Wiesel ML, Lanza F, Cazenave JP. Increased plasma levels of soluble platelet glycoprotein V in patients with acute myocardial infarction. J Thromb Haemost 2003 Aug;1(8):1846–1847. doi:10.1046/j.1538-7836.2003.00319.x.
   PubMed Web of Science ®Google Scholar
• Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Tedgui A, et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost 2004 Jul;2(7):1118–1126. doi:10.1111/j.1538-7836.2004.00805.x.
   PubMed Web of Science ®Google Scholar
• Atalar E, Haznedaroglu IC, Kilic H, Ozer N, Coskun S, Ozturk E, Aksoyek S, Ovunc K, Kirazli S, Ozmen F. Increased soluble glycoprotein V concentration during the acute onset of unstable angina pectoris in association with chronic cigarette smoking. Platelets 2005 Sep;16(6):329–333. doi:10.1080/00207230500120443.
   PubMed Web of Science ®Google Scholar
• Kamath S, Blann AD, Chin BSP, Lanza F, Aleil B, Cazenave JP, Lip GYH. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Eur Heart J 2002 Nov;23(22):1788–1795. doi:10.1053/euhj.2002.3259.
   PubMed Web of Science ®Google Scholar
• Wolff V, Aleil B, Giroud M, Lorenzini JL, Meyer N, Wiesel ML, Cazenave JP, Lanza F. Soluble platelet glycoprotein V is a marker of thrombosis in patients with ischemic stroke. Stroke 2005 Mar;36(3):e17–9. doi:10.1161/01.STR.0000155738.02753.4d.
   PubMed Web of Science ®Google Scholar
• Delabranche X, Boisramé-Helms J, Asfar P, Berger A, Mootien Y, Lavigne T, Grunebaum L, Lanza F, Gachet C, Freyssinet JM, et al. Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Intensive Care Med 2013 Oct;39(10):1695–1703. doi:10.1007/s00134-013-2993-x.
   PubMed Web of Science ®Google Scholar
• Gayol S, Kirchgesner T, Kopferschmitt J, Meyer N, Sauleau E, Wiesel ML, Cazenave JP, Gachet C, Lanza F. Evaluation of soluble glycoprotein v as a marker of venous thromboembolism. Thromb Haemost 2012 Jan;107(1):184–187. doi:10.1160/TH11-09-0630.
   PubMed Web of Science ®Google Scholar
• Morel O, Hugel B, Jesel L, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Freyssinet JM, Toti F. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 2004 Feb;91(2):345–353. doi:10.1160/TH03-05-0294.
   PubMed Web of Science ®Google Scholar
• Aleil B, Kessler L, Meyer N, Wiesel ML, Simeoni J, Cazenave JP, Pinget M, Gachet C, Lanza F. Plasma levels of soluble platelet glycoprotein V are linked to fasting blood glucose in patients with type 2 diabetes. Thromb Haemost 2008 Oct;100(4):713–715. doi:10.1160/TH08-04-0244.
   PubMed Web of Science ®Google Scholar
• Aleil B, Meyer N, Wolff V, Kientz D, Wiesel ML, Gachet C, Cazenave JP, Lanza F. Plasma glycoprotein V levels in the general population: normal distribution, associated parameters and implications for clinical studies. Thromb Haemost 2006 Oct;96(4):505–511. doi:10.1160/TH06-06-0296.
   PubMed Web of Science ®Google Scholar
• Bienz D, Schnippering W, Clemetson KJ. Glycoprotein V is not the thrombin activation receptor on human blood platelets. Blood 1986 Sep;68(3):720–725. doi:10.1182/blood.V68.3.720.720.
   PubMed Web of Science ®Google Scholar
• Kahn ML, Diacovo TG, Bainton DF, Lanza F, Trejo JA, Coughlin SR. Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and do not exhibit a Bernard-Soulier phenotype. Blood 1999 Dec 15;94(12):4112–4121. doi:10.1182/blood.V94.12.4112.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan V, Reeves PS, DeGuzman F, Deshpande U, Ministri-Madrid K, DuBridge RB, Phillips DR. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci U S A 1999 Nov 9;96(23):13336–13341. doi:10.1073/pnas.96.23.13336.
   PubMed Web of Science ®Google Scholar
• Moog S, Mangin P, Lenain N, Strassel C, Ravanat C, Schuhler S, Freund M, Santer M, Kahn M, Nieswandt B, et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 2001 Aug 15;98(4):1038–1046. doi:10.1182/blood.V98.4.1038.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan V, DeGuzman F, Bao M, Hall SW, Leung LL, Phillips DR. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci U S A 2001 Feb 13;98(4):1823–1828. doi:10.1073/pnas.98.4.1823.
   PubMed Web of Science ®Google Scholar
• Ni H, Ramakrishnan V, Ruggeri ZM, Papalia JM, Phillips DR, Wagner DD. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 2001 Jul 15;98(2):368–373. doi:10.1182/blood.V98.2.368.
   PubMed Web of Science ®Google Scholar
• Nonne C, Hechler B, Cazenave JP, Gachet C, Lanza F. Reassessment of in vivo thrombus formation in glycoprotein V deficient mice backcrossed on a C57Bl/6 strain. J Thromb Haemost 2008 Jan;6(1):210–212. doi:10.1111/j.1538-7836.2007.02825.x.
   PubMed Web of Science ®Google Scholar